What adverse reactions happened during this study?
For participants with relapsed/refractory leukemia, the most common adverse
reaction was headache.
For participants with treatment-na√Øve leukemia, the most common adverse
reactions were bleeding under the skin and headache.
13 | Clinical Study Results